Yin, W., Xiang, D., Wang, T., Zhang, Y., Pham, C. V., Zhou, S., . . . Duan, W. (2021). The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. Nature Portfolio.
Chicago Style (17th ed.) CitationYin, Wang, et al. The Inhibition of ABCB1/MDR1 or ABCG2/BCRP Enables Doxorubicin to Eliminate Liver Cancer Stem Cells. Nature Portfolio, 2021.
MLA (8th ed.) CitationYin, Wang, et al. The Inhibition of ABCB1/MDR1 or ABCG2/BCRP Enables Doxorubicin to Eliminate Liver Cancer Stem Cells. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.